| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Charcot-Marie-Tooth Disease | 27 | 2025 | 198 | 4.260 |
Why?
|
| Connexins | 13 | 2023 | 60 | 1.450 |
Why?
|
| High-Throughput Nucleotide Sequencing | 10 | 2025 | 887 | 1.330 |
Why?
|
| Peripheral Nervous System Diseases | 4 | 2024 | 121 | 1.310 |
Why?
|
| Pharmacogenetics | 7 | 2025 | 185 | 1.100 |
Why?
|
| Mutation | 33 | 2024 | 5903 | 1.090 |
Why?
|
| Genetic Testing | 10 | 2024 | 1016 | 1.090 |
Why?
|
| Myelin Sheath | 6 | 2016 | 122 | 0.940 |
Why?
|
| Schwann Cells | 9 | 2016 | 58 | 0.900 |
Why?
|
| Research Personnel | 1 | 2024 | 117 | 0.850 |
Why?
|
| Optic Nerve Diseases | 2 | 2022 | 88 | 0.850 |
Why?
|
| Gap Junctions | 4 | 2011 | 38 | 0.760 |
Why?
|
| Axons | 9 | 2016 | 371 | 0.740 |
Why?
|
| Sequence Analysis, DNA | 22 | 2023 | 1763 | 0.710 |
Why?
|
| Optic Nerve | 1 | 2021 | 114 | 0.660 |
Why?
|
| Nerve Tissue Proteins | 6 | 2008 | 1128 | 0.630 |
Why?
|
| Genotype | 20 | 2025 | 2569 | 0.600 |
Why?
|
| Thyroid Carcinoma, Anaplastic | 3 | 2024 | 16 | 0.600 |
Why?
|
| Cytochrome P-450 CYP2D6 | 4 | 2025 | 31 | 0.580 |
Why?
|
| Potassium Channels, Voltage-Gated | 3 | 2001 | 60 | 0.540 |
Why?
|
| Pedigree | 17 | 2025 | 1609 | 0.520 |
Why?
|
| Polymorphism, Single Nucleotide | 13 | 2023 | 2652 | 0.510 |
Why?
|
| Tomography, Optical Coherence | 1 | 2021 | 522 | 0.510 |
Why?
|
| Phenotype | 20 | 2025 | 4269 | 0.510 |
Why?
|
| Thyroid Neoplasms | 3 | 2024 | 189 | 0.500 |
Why?
|
| Neuroglia | 2 | 2008 | 206 | 0.480 |
Why?
|
| Humans | 114 | 2025 | 125466 | 0.480 |
Why?
|
| Alleles | 14 | 2023 | 1617 | 0.480 |
Why?
|
| Demyelinating Diseases | 5 | 2025 | 64 | 0.470 |
Why?
|
| Genomics | 10 | 2024 | 1520 | 0.470 |
Why?
|
| Mutation, Missense | 7 | 2025 | 879 | 0.460 |
Why?
|
| Sciatic Nerve | 9 | 2005 | 55 | 0.450 |
Why?
|
| Sodium Chloride Symporter Inhibitors | 3 | 2018 | 36 | 0.430 |
Why?
|
| Middle Aged | 43 | 2025 | 26833 | 0.430 |
Why?
|
| Pharmacogenomic Testing | 3 | 2025 | 37 | 0.430 |
Why?
|
| Male | 67 | 2025 | 61637 | 0.420 |
Why?
|
| Hydrochlorothiazide | 3 | 2018 | 71 | 0.420 |
Why?
|
| Ranvier's Nodes | 4 | 2001 | 72 | 0.410 |
Why?
|
| Blood Pressure | 5 | 2018 | 1377 | 0.410 |
Why?
|
| Evolution, Molecular | 13 | 2015 | 669 | 0.400 |
Why?
|
| Adult | 42 | 2025 | 29642 | 0.390 |
Why?
|
| Genes, Dominant | 6 | 2020 | 244 | 0.380 |
Why?
|
| Connexin 43 | 2 | 2011 | 29 | 0.380 |
Why?
|
| Genetic Variation | 9 | 2020 | 1505 | 0.380 |
Why?
|
| Neurofilament Proteins | 2 | 2009 | 28 | 0.380 |
Why?
|
| Antihypertensive Agents | 4 | 2018 | 415 | 0.370 |
Why?
|
| Membrane Proteins | 6 | 2012 | 1538 | 0.370 |
Why?
|
| Genes, Modifier | 3 | 2024 | 12 | 0.370 |
Why?
|
| Young Adult | 25 | 2025 | 9086 | 0.370 |
Why?
|
| Female | 61 | 2025 | 66904 | 0.370 |
Why?
|
| Cytochrome P-450 CYP2A6 | 3 | 2022 | 13 | 0.370 |
Why?
|
| Disease Models, Animal | 6 | 2024 | 4405 | 0.350 |
Why?
|
| Astrocytes | 2 | 2011 | 250 | 0.350 |
Why?
|
| Animals | 44 | 2024 | 34309 | 0.340 |
Why?
|
| Myelin P0 Protein | 6 | 2022 | 25 | 0.340 |
Why?
|
| Urinary Bladder Neoplasms | 6 | 2019 | 550 | 0.320 |
Why?
|
| Chromosome Mapping | 13 | 2018 | 1086 | 0.320 |
Why?
|
| Cell Membrane | 4 | 2008 | 464 | 0.320 |
Why?
|
| Computational Biology | 4 | 2024 | 819 | 0.320 |
Why?
|
| Aged | 22 | 2025 | 19747 | 0.310 |
Why?
|
| Gene Expression Profiling | 7 | 2018 | 1756 | 0.300 |
Why?
|
| Spinal Cord | 3 | 2013 | 305 | 0.300 |
Why?
|
| Scoliosis | 2 | 2023 | 134 | 0.300 |
Why?
|
| Chromosomes, Human, Pair 12 | 2 | 2006 | 92 | 0.290 |
Why?
|
| Nicotine | 2 | 2020 | 143 | 0.280 |
Why?
|
| Genome | 6 | 2014 | 481 | 0.280 |
Why?
|
| Neural Conduction | 7 | 2024 | 92 | 0.280 |
Why?
|
| Candida albicans | 4 | 2000 | 76 | 0.280 |
Why?
|
| Hearing Loss | 3 | 2015 | 136 | 0.280 |
Why?
|
| Pharmacogenomic Variants | 2 | 2018 | 35 | 0.280 |
Why?
|
| Nervous System | 1 | 2008 | 128 | 0.280 |
Why?
|
| Cytoskeletal Proteins | 5 | 2001 | 274 | 0.270 |
Why?
|
| Cell Communication | 6 | 2017 | 167 | 0.270 |
Why?
|
| DNA Mutational Analysis | 8 | 2016 | 809 | 0.260 |
Why?
|
| Synteny | 5 | 2016 | 76 | 0.260 |
Why?
|
| Polyneuropathies | 2 | 2016 | 29 | 0.260 |
Why?
|
| Potassium Channels | 3 | 2001 | 161 | 0.260 |
Why?
|
| Hypertension | 4 | 2018 | 1332 | 0.250 |
Why?
|
| Base Sequence | 17 | 2022 | 3109 | 0.250 |
Why?
|
| Cytochrome P-450 CYP2C19 | 2 | 2025 | 20 | 0.250 |
Why?
|
| Mice | 20 | 2023 | 17743 | 0.250 |
Why?
|
| Genetic Predisposition to Disease | 7 | 2016 | 3175 | 0.250 |
Why?
|
| Rats | 14 | 2024 | 3727 | 0.250 |
Why?
|
| Protein Prenylation | 1 | 2005 | 7 | 0.250 |
Why?
|
| Peripheral Nervous System | 3 | 2022 | 42 | 0.240 |
Why?
|
| Databases, Genetic | 3 | 2024 | 475 | 0.240 |
Why?
|
| Genes, Insect | 3 | 2015 | 123 | 0.240 |
Why?
|
| Molecular Sequence Data | 16 | 2015 | 3897 | 0.240 |
Why?
|
| Phosphoproteins | 4 | 2017 | 420 | 0.240 |
Why?
|
| Genetic Association Studies | 5 | 2023 | 780 | 0.240 |
Why?
|
| Phylogeny | 7 | 2015 | 687 | 0.230 |
Why?
|
| TRPV Cation Channels | 1 | 2025 | 33 | 0.230 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2025 | 34 | 0.230 |
Why?
|
| Smoking Cessation | 2 | 2024 | 198 | 0.230 |
Why?
|
| Cell Differentiation | 3 | 2008 | 1908 | 0.230 |
Why?
|
| Adolescent | 22 | 2025 | 19448 | 0.220 |
Why?
|
| Exons | 6 | 2022 | 801 | 0.220 |
Why?
|
| Genome, Human | 6 | 2019 | 1293 | 0.220 |
Why?
|
| Genome, Insect | 3 | 2016 | 98 | 0.220 |
Why?
|
| Graft Survival | 4 | 2017 | 531 | 0.220 |
Why?
|
| Nicotinic Agonists | 1 | 2024 | 45 | 0.220 |
Why?
|
| Disease Progression | 6 | 2022 | 2083 | 0.220 |
Why?
|
| Myelin Proteins | 5 | 2024 | 75 | 0.210 |
Why?
|
| GTP Phosphohydrolases | 3 | 2020 | 147 | 0.210 |
Why?
|
| Exome | 5 | 2016 | 1034 | 0.210 |
Why?
|
| Psychodidae | 1 | 2023 | 14 | 0.210 |
Why?
|
| Kidney Transplantation | 3 | 2017 | 651 | 0.210 |
Why?
|
| Phlebotomus | 1 | 2023 | 17 | 0.210 |
Why?
|
| HLA-B Antigens | 3 | 2008 | 28 | 0.210 |
Why?
|
| Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 1 | 2022 | 4 | 0.210 |
Why?
|
| Neurons | 3 | 2017 | 1943 | 0.210 |
Why?
|
| Mitochondrial Proteins | 3 | 2020 | 228 | 0.200 |
Why?
|
| Leishmaniasis, Cutaneous | 1 | 2023 | 48 | 0.200 |
Why?
|
| Leishmania | 1 | 2023 | 29 | 0.200 |
Why?
|
| Cohort Studies | 6 | 2024 | 4843 | 0.200 |
Why?
|
| Ring Chromosomes | 1 | 2022 | 13 | 0.200 |
Why?
|
| Mice, Knockout | 5 | 2022 | 3753 | 0.200 |
Why?
|
| Nephritis, Hereditary | 1 | 2022 | 21 | 0.200 |
Why?
|
| Adenocarcinoma | 2 | 2024 | 1025 | 0.190 |
Why?
|
| Cytochrome P-450 CYP2C8 | 1 | 2022 | 3 | 0.190 |
Why?
|
| Cytochrome P-450 CYP2C9 | 1 | 2022 | 3 | 0.190 |
Why?
|
| Neurology | 1 | 2024 | 107 | 0.190 |
Why?
|
| Hematuria | 1 | 2022 | 54 | 0.190 |
Why?
|
| Severity of Illness Index | 7 | 2025 | 2913 | 0.190 |
Why?
|
| Papilledema | 1 | 2022 | 78 | 0.190 |
Why?
|
| Microfilament Proteins | 2 | 2017 | 278 | 0.190 |
Why?
|
| Promoter Regions, Genetic | 5 | 2017 | 1338 | 0.190 |
Why?
|
| Atenolol | 2 | 2018 | 43 | 0.180 |
Why?
|
| Microvilli | 1 | 2001 | 71 | 0.180 |
Why?
|
| Nerve Fibers, Myelinated | 2 | 2001 | 81 | 0.180 |
Why?
|
| Child, Preschool | 14 | 2025 | 14143 | 0.180 |
Why?
|
| Polymorphism, Genetic | 5 | 2018 | 818 | 0.180 |
Why?
|
| Child | 19 | 2025 | 24607 | 0.180 |
Why?
|
| High-Throughput Screening Assays | 1 | 2021 | 99 | 0.180 |
Why?
|
| Nerve Fibers | 1 | 2021 | 75 | 0.180 |
Why?
|
| Diabetic Neuropathies | 1 | 2001 | 58 | 0.180 |
Why?
|
| Blood Proteins | 1 | 2001 | 124 | 0.180 |
Why?
|
| Endometrial Neoplasms | 2 | 2012 | 99 | 0.180 |
Why?
|
| Mosaicism | 1 | 2022 | 239 | 0.170 |
Why?
|
| Sural Nerve | 4 | 2016 | 47 | 0.170 |
Why?
|
| Cytochrome P-450 CYP2B6 | 1 | 2020 | 14 | 0.170 |
Why?
|
| Chlorthalidone | 2 | 2017 | 27 | 0.170 |
Why?
|
| Urothelium | 2 | 2019 | 60 | 0.170 |
Why?
|
| Age of Onset | 4 | 2020 | 601 | 0.170 |
Why?
|
| Chromosomes | 2 | 2015 | 207 | 0.170 |
Why?
|
| Mice, Transgenic | 6 | 2011 | 2414 | 0.170 |
Why?
|
| Nervous System Diseases | 1 | 2024 | 375 | 0.170 |
Why?
|
| HeLa Cells | 4 | 2013 | 808 | 0.160 |
Why?
|
| Karyotyping | 2 | 2022 | 323 | 0.160 |
Why?
|
| Forkhead Transcription Factors | 2 | 2024 | 360 | 0.160 |
Why?
|
| Patch-Clamp Techniques | 4 | 2017 | 283 | 0.160 |
Why?
|
| Peripheral Nerves | 5 | 2006 | 85 | 0.160 |
Why?
|
| Autopsy | 2 | 2016 | 110 | 0.160 |
Why?
|
| Silver-Russell Syndrome | 1 | 2019 | 2 | 0.160 |
Why?
|
| Transcriptome | 2 | 2017 | 977 | 0.160 |
Why?
|
| Protein Structure, Tertiary | 3 | 2011 | 767 | 0.160 |
Why?
|
| Oligodendroglia | 3 | 2007 | 75 | 0.160 |
Why?
|
| Genetic Markers | 6 | 2020 | 605 | 0.160 |
Why?
|
| Bestrophins | 1 | 2018 | 4 | 0.160 |
Why?
|
| Software | 3 | 2018 | 687 | 0.150 |
Why?
|
| Genes, Tumor Suppressor | 3 | 2012 | 214 | 0.150 |
Why?
|
| Clonal Evolution | 1 | 2019 | 41 | 0.150 |
Why?
|
| Clinical Protocols | 1 | 2020 | 240 | 0.150 |
Why?
|
| GTPase-Activating Proteins | 1 | 2019 | 87 | 0.150 |
Why?
|
| Foot | 1 | 2019 | 62 | 0.150 |
Why?
|
| Smoking | 2 | 2024 | 1049 | 0.150 |
Why?
|
| Brain | 4 | 2014 | 3012 | 0.150 |
Why?
|
| Facies | 1 | 2019 | 153 | 0.150 |
Why?
|
| Arrhythmogenic Right Ventricular Dysplasia | 2 | 2010 | 18 | 0.150 |
Why?
|
| Retinoblastoma Protein | 3 | 2008 | 81 | 0.150 |
Why?
|
| Immunohistochemistry | 5 | 2010 | 1703 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 1998 | 74 | 0.150 |
Why?
|
| Muscle Weakness | 1 | 2019 | 85 | 0.150 |
Why?
|
| Registries | 1 | 2025 | 1434 | 0.150 |
Why?
|
| Carcinogenesis | 2 | 2019 | 340 | 0.150 |
Why?
|
| HLA-A Antigens | 2 | 2008 | 35 | 0.150 |
Why?
|
| Repressor Proteins | 2 | 2024 | 826 | 0.150 |
Why?
|
| Genes, Fungal | 3 | 2000 | 63 | 0.150 |
Why?
|
| Renin | 1 | 2018 | 93 | 0.150 |
Why?
|
| Gene Expression | 3 | 2016 | 1554 | 0.140 |
Why?
|
| Longitudinal Studies | 4 | 2023 | 1334 | 0.140 |
Why?
|
| Erythropoietin | 1 | 1998 | 106 | 0.140 |
Why?
|
| Models, Theoretical | 1 | 2020 | 364 | 0.140 |
Why?
|
| Expressed Sequence Tags | 5 | 2006 | 79 | 0.140 |
Why?
|
| Foot Deformities, Congenital | 1 | 2017 | 16 | 0.140 |
Why?
|
| Nuclear Proteins | 3 | 2019 | 1284 | 0.140 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2018 | 101 | 0.140 |
Why?
|
| Kv1.2 Potassium Channel | 3 | 2001 | 12 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-vav | 1 | 2017 | 11 | 0.140 |
Why?
|
| Aged, 80 and over | 9 | 2020 | 6559 | 0.140 |
Why?
|
| Ankle | 1 | 2017 | 29 | 0.140 |
Why?
|
| Genes | 3 | 2006 | 447 | 0.140 |
Why?
|
| Cardiomyopathies | 2 | 2016 | 500 | 0.140 |
Why?
|
| Internet | 2 | 2018 | 376 | 0.140 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2021 | 543 | 0.140 |
Why?
|
| Kv1.1 Potassium Channel | 3 | 2001 | 40 | 0.140 |
Why?
|
| Multigene Family | 2 | 2015 | 301 | 0.140 |
Why?
|
| COS Cells | 2 | 2008 | 275 | 0.140 |
Why?
|
| Base Composition | 4 | 2008 | 69 | 0.130 |
Why?
|
| Manduca | 1 | 2016 | 6 | 0.130 |
Why?
|
| Neprilysin | 1 | 2016 | 19 | 0.130 |
Why?
|
| Diuretics | 1 | 2017 | 171 | 0.130 |
Why?
|
| Neoplasm Invasiveness | 2 | 2013 | 625 | 0.130 |
Why?
|
| Visual Acuity | 1 | 2021 | 817 | 0.130 |
Why?
|
| Mutant Proteins | 1 | 2017 | 114 | 0.130 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2021 | 1980 | 0.130 |
Why?
|
| Orthopedic Procedures | 1 | 2017 | 69 | 0.130 |
Why?
|
| Transfection | 3 | 2017 | 1076 | 0.130 |
Why?
|
| Carcinoma | 1 | 2019 | 290 | 0.130 |
Why?
|
| Myelin P2 Protein | 1 | 2016 | 9 | 0.130 |
Why?
|
| Animals, Newborn | 3 | 2011 | 1018 | 0.130 |
Why?
|
| Actins | 2 | 2009 | 345 | 0.130 |
Why?
|
| Death, Sudden | 1 | 2016 | 45 | 0.130 |
Why?
|
| Cholesterol, HDL | 2 | 2013 | 359 | 0.130 |
Why?
|
| Amino Acid Sequence | 8 | 2018 | 2717 | 0.130 |
Why?
|
| Lymphatic Diseases | 1 | 1996 | 31 | 0.130 |
Why?
|
| Aortic Aneurysm, Thoracic | 4 | 2009 | 662 | 0.130 |
Why?
|
| DNA Methylation | 3 | 2019 | 1051 | 0.130 |
Why?
|
| Linkage Disequilibrium | 3 | 2018 | 309 | 0.120 |
Why?
|
| Receptors, KIR | 2 | 2013 | 8 | 0.120 |
Why?
|
| Residence Characteristics | 1 | 2018 | 277 | 0.120 |
Why?
|
| Muscle Proteins | 1 | 2018 | 413 | 0.120 |
Why?
|
| Mobility Limitation | 1 | 2015 | 26 | 0.120 |
Why?
|
| United States | 4 | 2024 | 10926 | 0.120 |
Why?
|
| Femoral Nerve | 2 | 2005 | 8 | 0.120 |
Why?
|
| Alanine-tRNA Ligase | 1 | 2015 | 2 | 0.120 |
Why?
|
| Drosophila melanogaster | 3 | 2014 | 771 | 0.120 |
Why?
|
| Cell Line, Tumor | 5 | 2021 | 3419 | 0.120 |
Why?
|
| Bees | 1 | 2015 | 26 | 0.120 |
Why?
|
| Plant Tumors | 1 | 2015 | 4 | 0.120 |
Why?
|
| Triticum | 1 | 2015 | 34 | 0.120 |
Why?
|
| Diptera | 1 | 2015 | 22 | 0.120 |
Why?
|
| Arthropods | 1 | 2014 | 26 | 0.120 |
Why?
|
| Heterozygote | 3 | 2016 | 673 | 0.120 |
Why?
|
| RNA, Messenger | 8 | 2017 | 2812 | 0.110 |
Why?
|
| Pelizaeus-Merzbacher Disease | 1 | 2014 | 22 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 3 | 2 | 2006 | 96 | 0.110 |
Why?
|
| DNA Copy Number Variations | 2 | 2018 | 963 | 0.110 |
Why?
|
| Cross-Sectional Studies | 5 | 2025 | 3433 | 0.110 |
Why?
|
| Motor Neuron Disease | 2 | 2013 | 15 | 0.110 |
Why?
|
| Antibody Specificity | 2 | 2007 | 204 | 0.110 |
Why?
|
| Bulbar Palsy, Progressive | 1 | 2013 | 8 | 0.110 |
Why?
|
| Membrane Potentials | 2 | 2014 | 307 | 0.110 |
Why?
|
| Cells, Cultured | 6 | 2011 | 3043 | 0.110 |
Why?
|
| Myocytes, Cardiac | 2 | 2011 | 640 | 0.110 |
Why?
|
| Molecular Sequence Annotation | 1 | 2014 | 148 | 0.110 |
Why?
|
| Green Fluorescent Proteins | 2 | 2014 | 387 | 0.110 |
Why?
|
| Social Behavior | 1 | 2015 | 209 | 0.110 |
Why?
|
| Biomarkers, Tumor | 1 | 2021 | 1534 | 0.110 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2013 | 296 | 0.110 |
Why?
|
| Neutropenia | 1 | 1995 | 199 | 0.110 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2019 | 501 | 0.100 |
Why?
|
| Chromosome Breakage | 3 | 2008 | 167 | 0.100 |
Why?
|
| Sensory Receptor Cells | 1 | 2013 | 53 | 0.100 |
Why?
|
| Apolipoproteins A | 1 | 2013 | 48 | 0.100 |
Why?
|
| Genes, X-Linked | 1 | 2013 | 59 | 0.100 |
Why?
|
| Haplotypes | 5 | 2022 | 521 | 0.100 |
Why?
|
| DNA Transposable Elements | 4 | 2008 | 182 | 0.100 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 7 | 2008 | 369 | 0.100 |
Why?
|
| Fenofibrate | 1 | 2013 | 59 | 0.100 |
Why?
|
| Carcinoma in Situ | 1 | 2013 | 71 | 0.100 |
Why?
|
| Correction of Hearing Impairment | 1 | 2012 | 1 | 0.100 |
Why?
|
| Persons With Hearing Impairments | 1 | 2012 | 2 | 0.100 |
Why?
|
| Spiral Ganglion | 1 | 2012 | 10 | 0.100 |
Why?
|
| Abnormalities, Multiple | 1 | 2019 | 960 | 0.100 |
Why?
|
| Angiotensin II | 2 | 2018 | 167 | 0.100 |
Why?
|
| Nerve Regeneration | 3 | 2001 | 74 | 0.100 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2013 | 97 | 0.100 |
Why?
|
| Behavior, Animal | 1 | 2015 | 491 | 0.100 |
Why?
|
| Infant | 6 | 2025 | 12601 | 0.100 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 1714 | 0.100 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2013 | 143 | 0.100 |
Why?
|
| Oncogenes | 1 | 2012 | 176 | 0.090 |
Why?
|
| Mutant Chimeric Proteins | 2 | 2008 | 16 | 0.090 |
Why?
|
| Cochlear Implantation | 1 | 2012 | 50 | 0.090 |
Why?
|
| Hemostasis | 1 | 2012 | 70 | 0.090 |
Why?
|
| Class Ia Phosphatidylinositol 3-Kinase | 1 | 2011 | 7 | 0.090 |
Why?
|
| Cochlear Implants | 1 | 2012 | 52 | 0.090 |
Why?
|
| Spectral Karyotyping | 1 | 2011 | 8 | 0.090 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 2 | 2001 | 79 | 0.090 |
Why?
|
| Receptors, Cell Surface | 3 | 2002 | 477 | 0.090 |
Why?
|
| Time Factors | 6 | 2020 | 6323 | 0.090 |
Why?
|
| Xenopus | 1 | 2011 | 112 | 0.090 |
Why?
|
| Gene Frequency | 3 | 2022 | 725 | 0.090 |
Why?
|
| Biophysics | 1 | 2011 | 50 | 0.090 |
Why?
|
| Desmosomes | 2 | 2010 | 7 | 0.090 |
Why?
|
| Contig Mapping | 4 | 2006 | 55 | 0.090 |
Why?
|
| HLA-DQ Antigens | 2 | 2007 | 21 | 0.090 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2011 | 106 | 0.090 |
Why?
|
| Immunoprecipitation | 1 | 2011 | 199 | 0.090 |
Why?
|
| Family Health | 2 | 2009 | 259 | 0.090 |
Why?
|
| Genome-Wide Association Study | 4 | 2019 | 1694 | 0.090 |
Why?
|
| Spinocerebellar Ataxias | 1 | 2013 | 252 | 0.090 |
Why?
|
| Coculture Techniques | 1 | 2011 | 228 | 0.090 |
Why?
|
| DNA | 2 | 2006 | 1619 | 0.090 |
Why?
|
| Ankyrins | 2 | 2001 | 95 | 0.090 |
Why?
|
| Renal Insufficiency | 1 | 2013 | 239 | 0.090 |
Why?
|
| CpG Islands | 3 | 2006 | 330 | 0.090 |
Why?
|
| Dyslipidemias | 1 | 2013 | 235 | 0.080 |
Why?
|
| Venous Thrombosis | 1 | 2012 | 167 | 0.080 |
Why?
|
| Electric Stimulation | 1 | 2011 | 325 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 2 | 2011 | 4420 | 0.080 |
Why?
|
| Serine | 2 | 2013 | 175 | 0.080 |
Why?
|
| HLA Antigens | 2 | 2007 | 237 | 0.080 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2010 | 64 | 0.080 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2009 | 124 | 0.080 |
Why?
|
| Family | 3 | 2018 | 567 | 0.080 |
Why?
|
| Chromosomes, Human, X | 2 | 2013 | 158 | 0.080 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2011 | 260 | 0.080 |
Why?
|
| Pan troglodytes | 2 | 2006 | 71 | 0.080 |
Why?
|
| HLA-C Antigens | 1 | 2009 | 6 | 0.080 |
Why?
|
| Gene Duplication | 3 | 2006 | 363 | 0.080 |
Why?
|
| Cation Transport Proteins | 1 | 2010 | 94 | 0.080 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2011 | 339 | 0.080 |
Why?
|
| Prospective Studies | 4 | 2023 | 6174 | 0.080 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2009 | 319 | 0.080 |
Why?
|
| Adenosine Triphosphatases | 1 | 2010 | 202 | 0.080 |
Why?
|
| Microsatellite Repeats | 2 | 2008 | 222 | 0.080 |
Why?
|
| Adenocarcinoma, Bronchiolo-Alveolar | 1 | 2008 | 11 | 0.080 |
Why?
|
| Moyamoya Disease | 1 | 2009 | 38 | 0.080 |
Why?
|
| Spastic Paraplegia, Hereditary | 1 | 2008 | 29 | 0.080 |
Why?
|
| Physical Chromosome Mapping | 4 | 2002 | 56 | 0.080 |
Why?
|
| Glutamic Acid | 1 | 2009 | 203 | 0.080 |
Why?
|
| Melanoma | 1 | 1996 | 943 | 0.080 |
Why?
|
| Transcription Factors | 4 | 2017 | 2603 | 0.080 |
Why?
|
| Biomarkers | 1 | 2017 | 3103 | 0.080 |
Why?
|
| Tribolium | 1 | 2008 | 7 | 0.070 |
Why?
|
| Gene Rearrangement | 4 | 2015 | 323 | 0.070 |
Why?
|
| Genes, Neoplasm | 1 | 2008 | 83 | 0.070 |
Why?
|
| Ornithine Carbamoyltransferase | 1 | 1988 | 17 | 0.070 |
Why?
|
| Chromosome Inversion | 3 | 2006 | 73 | 0.070 |
Why?
|
| Reproducibility of Results | 3 | 2024 | 2904 | 0.070 |
Why?
|
| Cell Adhesion Molecules | 2 | 2017 | 231 | 0.070 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2007 | 36 | 0.070 |
Why?
|
| Cerebral Cortex | 1 | 2011 | 455 | 0.070 |
Why?
|
| Conserved Sequence | 2 | 2005 | 291 | 0.070 |
Why?
|
| Sequence Alignment | 4 | 2013 | 619 | 0.070 |
Why?
|
| Central Nervous System | 2 | 2017 | 257 | 0.070 |
Why?
|
| Genotyping Techniques | 2 | 2018 | 103 | 0.070 |
Why?
|
| Models, Molecular | 5 | 2010 | 1084 | 0.070 |
Why?
|
| Apoptosis | 3 | 2021 | 1817 | 0.070 |
Why?
|
| Gene Expression Regulation | 4 | 2019 | 2524 | 0.070 |
Why?
|
| Myosin Heavy Chains | 1 | 2007 | 76 | 0.070 |
Why?
|
| Pancreatic Neoplasms | 1 | 2013 | 690 | 0.070 |
Why?
|
| Tissue Distribution | 2 | 2005 | 391 | 0.070 |
Why?
|
| Neurologic Examination | 2 | 2020 | 194 | 0.070 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2001 | 1006 | 0.070 |
Why?
|
| In Vitro Techniques | 2 | 2019 | 972 | 0.070 |
Why?
|
| Hominidae | 1 | 2006 | 27 | 0.070 |
Why?
|
| Desmoplakins | 1 | 2006 | 10 | 0.070 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2008 | 188 | 0.070 |
Why?
|
| Short Interspersed Nucleotide Elements | 1 | 2006 | 17 | 0.060 |
Why?
|
| DNA, Fungal | 3 | 1995 | 77 | 0.060 |
Why?
|
| Sequence Deletion | 2 | 2006 | 528 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2024 | 1242 | 0.060 |
Why?
|
| Threonine | 1 | 2006 | 60 | 0.060 |
Why?
|
| Introns | 3 | 2017 | 300 | 0.060 |
Why?
|
| Tissue Donors | 1 | 2009 | 483 | 0.060 |
Why?
|
| Vascular Diseases | 1 | 2007 | 155 | 0.060 |
Why?
|
| Codon, Terminator | 1 | 2005 | 25 | 0.060 |
Why?
|
| Food, Genetically Modified | 1 | 2005 | 4 | 0.060 |
Why?
|
| Biological Evolution | 1 | 2006 | 227 | 0.060 |
Why?
|
| Patient Selection | 2 | 2024 | 697 | 0.060 |
Why?
|
| Genetic Linkage | 5 | 2005 | 454 | 0.060 |
Why?
|
| HLA-DR Antigens | 1 | 2005 | 77 | 0.060 |
Why?
|
| Methionine | 1 | 2006 | 102 | 0.060 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2007 | 340 | 0.060 |
Why?
|
| Mutagenesis, Insertional | 1 | 2006 | 150 | 0.060 |
Why?
|
| Selenoproteins | 2 | 2015 | 13 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 16 | 2 | 2006 | 150 | 0.060 |
Why?
|
| Biotechnology | 1 | 2005 | 56 | 0.060 |
Why?
|
| Amino Acid Motifs | 1 | 2005 | 200 | 0.060 |
Why?
|
| Larva | 2 | 2016 | 248 | 0.060 |
Why?
|
| Myelin-Associated Glycoprotein | 2 | 2001 | 6 | 0.060 |
Why?
|
| Public Opinion | 1 | 2005 | 56 | 0.060 |
Why?
|
| L-Iditol 2-Dehydrogenase | 1 | 2024 | 1 | 0.060 |
Why?
|
| Sorbitol | 1 | 2024 | 8 | 0.060 |
Why?
|
| Cysteine | 1 | 2005 | 139 | 0.060 |
Why?
|
| Military Medicine | 1 | 2025 | 49 | 0.060 |
Why?
|
| Histocompatibility Testing | 3 | 2013 | 143 | 0.060 |
Why?
|
| Cell Count | 1 | 2005 | 252 | 0.060 |
Why?
|
| Rats, Inbred BN | 1 | 2004 | 16 | 0.060 |
Why?
|
| Glycine | 1 | 2005 | 168 | 0.060 |
Why?
|
| Neuromuscular Diseases | 1 | 2025 | 57 | 0.060 |
Why?
|
| Microscopy, Electron | 2 | 2001 | 396 | 0.060 |
Why?
|
| Drug Interactions | 1 | 2025 | 255 | 0.060 |
Why?
|
| Motor Neurons | 1 | 2005 | 138 | 0.060 |
Why?
|
| Bupropion | 1 | 2024 | 29 | 0.050 |
Why?
|
| Aging | 4 | 2016 | 1182 | 0.050 |
Why?
|
| Italy | 1 | 2024 | 114 | 0.050 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2022 | 772 | 0.050 |
Why?
|
| DNA, Ribosomal | 2 | 1995 | 53 | 0.050 |
Why?
|
| Factor Analysis, Statistical | 1 | 2024 | 234 | 0.050 |
Why?
|
| Euchromatin | 1 | 2002 | 13 | 0.050 |
Why?
|
| Alternative Splicing | 3 | 2001 | 355 | 0.050 |
Why?
|
| Models, Animal | 1 | 2005 | 456 | 0.050 |
Why?
|
| Cell Line, Transformed | 2 | 2014 | 169 | 0.050 |
Why?
|
| Scotoma | 1 | 2022 | 16 | 0.050 |
Why?
|
| Operon | 1 | 1982 | 51 | 0.050 |
Why?
|
| Yeasts | 1 | 1982 | 43 | 0.050 |
Why?
|
| Collagen Type IV | 1 | 2022 | 20 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2022 | 79 | 0.050 |
Why?
|
| Coronary Artery Disease | 1 | 2009 | 805 | 0.050 |
Why?
|
| Syndrome | 2 | 2019 | 1122 | 0.050 |
Why?
|
| Chromosomes, Fungal | 2 | 2000 | 49 | 0.050 |
Why?
|
| Chronic Disease | 2 | 1997 | 1192 | 0.050 |
Why?
|
| Vitamin K Epoxide Reductases | 1 | 2022 | 5 | 0.050 |
Why?
|
| Headache | 1 | 2022 | 107 | 0.050 |
Why?
|
| Adherens Junctions | 1 | 2001 | 15 | 0.050 |
Why?
|
| Receptors, Odorant | 2 | 2014 | 36 | 0.050 |
Why?
|
| Carcinogenicity Tests | 1 | 2021 | 20 | 0.050 |
Why?
|
| Ambulatory Care Facilities | 1 | 2024 | 225 | 0.050 |
Why?
|
| Contactins | 1 | 2001 | 3 | 0.050 |
Why?
|
| Rats, Inbred BB | 1 | 2001 | 5 | 0.050 |
Why?
|
| Autoantigens | 1 | 2022 | 118 | 0.050 |
Why?
|
| Prognosis | 2 | 2021 | 4691 | 0.050 |
Why?
|
| ras Proteins | 2 | 2013 | 139 | 0.050 |
Why?
|
| Neurites | 1 | 2001 | 42 | 0.050 |
Why?
|
| Actin Cytoskeleton | 1 | 2001 | 44 | 0.050 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2013 | 158 | 0.050 |
Why?
|
| Germ Cells | 1 | 2022 | 196 | 0.050 |
Why?
|
| Nerve Growth Factors | 1 | 2001 | 71 | 0.050 |
Why?
|
| Stroke | 1 | 2009 | 981 | 0.040 |
Why?
|
| Penetrance | 2 | 2016 | 102 | 0.040 |
Why?
|
| Wheelchairs | 1 | 2020 | 16 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2010 | 658 | 0.040 |
Why?
|
| Cloning, Molecular | 2 | 2001 | 898 | 0.040 |
Why?
|
| Vision Disorders | 1 | 2022 | 211 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2001 | 104 | 0.040 |
Why?
|
| Orthotic Devices | 1 | 2020 | 18 | 0.040 |
Why?
|
| Sodium Channels | 1 | 2001 | 110 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2001 | 120 | 0.040 |
Why?
|
| Cadherins | 1 | 2001 | 172 | 0.040 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2000 | 429 | 0.040 |
Why?
|
| Alaska Natives | 1 | 2020 | 1 | 0.040 |
Why?
|
| Alaska | 1 | 2020 | 5 | 0.040 |
Why?
|
| Fibroblast Growth Factors | 1 | 2001 | 157 | 0.040 |
Why?
|
| Myelin Proteolipid Protein | 1 | 2000 | 27 | 0.040 |
Why?
|
| Retrospective Studies | 4 | 2024 | 16362 | 0.040 |
Why?
|
| Liver Transplantation | 1 | 2009 | 1043 | 0.040 |
Why?
|
| Translocation, Genetic | 1 | 2022 | 358 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2009 | 5174 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2000 | 67 | 0.040 |
Why?
|
| Lac Operon | 1 | 2000 | 96 | 0.040 |
Why?
|
| Indians, North American | 1 | 2020 | 58 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2022 | 309 | 0.040 |
Why?
|
| Drosophila | 1 | 2005 | 776 | 0.040 |
Why?
|
| Genes, Recessive | 1 | 2020 | 184 | 0.040 |
Why?
|
| RNA Splice Sites | 2 | 2014 | 90 | 0.040 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2021 | 193 | 0.040 |
Why?
|
| Chromosomes, Artificial, Bacterial | 3 | 2008 | 93 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2021 | 1077 | 0.040 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2000 | 89 | 0.040 |
Why?
|
| RNA, Untranslated | 2 | 2014 | 114 | 0.040 |
Why?
|
| Tangier Disease | 1 | 1999 | 5 | 0.040 |
Why?
|
| DNA Fingerprinting | 2 | 2001 | 108 | 0.040 |
Why?
|
| Chromosome Aberrations | 1 | 2022 | 620 | 0.040 |
Why?
|
| Antigens, CD | 1 | 2001 | 430 | 0.040 |
Why?
|
| Cell Proliferation | 2 | 2021 | 2372 | 0.040 |
Why?
|
| Loss of Heterozygosity | 3 | 2007 | 130 | 0.040 |
Why?
|
| Macaca mulatta | 2 | 2013 | 490 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2013 | 559 | 0.040 |
Why?
|
| Caenorhabditis elegans | 1 | 2000 | 227 | 0.040 |
Why?
|
| Sacrum | 1 | 1998 | 30 | 0.040 |
Why?
|
| Mucous Membrane | 1 | 2019 | 89 | 0.040 |
Why?
|
| Neurilemmoma | 1 | 2019 | 44 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 914 | 0.040 |
Why?
|
| Genes, Homeobox | 1 | 1998 | 71 | 0.040 |
Why?
|
| Spermatozoa | 1 | 2000 | 235 | 0.040 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2000 | 216 | 0.040 |
Why?
|
| Centromere | 3 | 2005 | 108 | 0.040 |
Why?
|
| Bone Diseases | 1 | 1998 | 44 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2008 | 1654 | 0.040 |
Why?
|
| Precancerous Conditions | 1 | 2001 | 284 | 0.040 |
Why?
|
| Search Engine | 1 | 2018 | 5 | 0.040 |
Why?
|
| Oocytes | 1 | 2000 | 299 | 0.040 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 1999 | 190 | 0.040 |
Why?
|
| Telomere | 3 | 2008 | 220 | 0.040 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2019 | 70 | 0.040 |
Why?
|
| CCAAT-Enhancer-Binding Protein-delta | 1 | 2017 | 9 | 0.040 |
Why?
|
| Tissue Banks | 1 | 2018 | 27 | 0.040 |
Why?
|
| Phosphorylation | 2 | 2012 | 1638 | 0.040 |
Why?
|
| GTP-Binding Proteins | 1 | 1998 | 179 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 367 | 0.040 |
Why?
|
| Collagen | 1 | 1999 | 317 | 0.040 |
Why?
|
| DNA, Neoplasm | 2 | 2013 | 306 | 0.040 |
Why?
|
| Trans-Activators | 1 | 2001 | 801 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2021 | 565 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2001 | 1033 | 0.040 |
Why?
|
| Inflammation | 2 | 2012 | 1446 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 2 | 2006 | 1587 | 0.030 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2009 | 158 | 0.030 |
Why?
|
| Isoenzymes | 1 | 2018 | 232 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 13 | 2 | 2008 | 49 | 0.030 |
Why?
|
| Uric Acid | 1 | 2017 | 95 | 0.030 |
Why?
|
| Glycoproteins | 1 | 1999 | 367 | 0.030 |
Why?
|
| User-Computer Interface | 1 | 2018 | 155 | 0.030 |
Why?
|
| HLA-DQ beta-Chains | 2 | 2007 | 15 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2014 | 3603 | 0.030 |
Why?
|
| Pupa | 1 | 2016 | 21 | 0.030 |
Why?
|
| Precision Medicine | 1 | 2020 | 321 | 0.030 |
Why?
|
| Potassium | 1 | 2017 | 285 | 0.030 |
Why?
|
| Consent Forms | 1 | 2016 | 22 | 0.030 |
Why?
|
| Coroners and Medical Examiners | 1 | 2016 | 15 | 0.030 |
Why?
|
| Axotomy | 3 | 2001 | 10 | 0.030 |
Why?
|
| Germany | 2 | 2009 | 66 | 0.030 |
Why?
|
| Radiography | 1 | 2019 | 809 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2008 | 2519 | 0.030 |
Why?
|
| Survival Rate | 1 | 2021 | 2050 | 0.030 |
Why?
|
| RNA | 2 | 2013 | 574 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2019 | 363 | 0.030 |
Why?
|
| Allografts | 1 | 2017 | 173 | 0.030 |
Why?
|
| Diagnosis | 1 | 2016 | 29 | 0.030 |
Why?
|
| Vitiligo | 1 | 1996 | 7 | 0.030 |
Why?
|
| Models, Genetic | 2 | 2015 | 761 | 0.030 |
Why?
|
| ROC Curve | 1 | 2017 | 572 | 0.030 |
Why?
|
| Cell Line | 2 | 2017 | 2755 | 0.030 |
Why?
|
| Confidentiality | 1 | 2016 | 99 | 0.030 |
Why?
|
| DNA, Recombinant | 2 | 1988 | 105 | 0.030 |
Why?
|
| Bee Venoms | 1 | 2015 | 7 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2017 | 314 | 0.030 |
Why?
|
| Chemoreceptor Cells | 1 | 2015 | 14 | 0.030 |
Why?
|
| Interspersed Repetitive Sequences | 1 | 2015 | 27 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 1998 | 556 | 0.030 |
Why?
|
| Kidney | 1 | 2022 | 1363 | 0.030 |
Why?
|
| Disclosure | 1 | 2016 | 150 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2012 | 3310 | 0.030 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2015 | 65 | 0.030 |
Why?
|
| Sequence Homology | 1 | 2015 | 63 | 0.030 |
Why?
|
| Circadian Rhythm Signaling Peptides and Proteins | 1 | 2014 | 8 | 0.030 |
Why?
|
| Cell Cycle Proteins | 2 | 2014 | 664 | 0.030 |
Why?
|
| Adaptation, Biological | 1 | 2015 | 32 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 2005 | 291 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 2057 | 0.030 |
Why?
|
| Sex Chromosomes | 1 | 2014 | 35 | 0.030 |
Why?
|
| Amyloid beta-Peptides | 1 | 2016 | 212 | 0.030 |
Why?
|
| Sexual Behavior, Animal | 1 | 2015 | 87 | 0.030 |
Why?
|
| Position-Specific Scoring Matrices | 1 | 2014 | 9 | 0.030 |
Why?
|
| Opportunistic Infections | 1 | 1995 | 79 | 0.030 |
Why?
|
| Open Reading Frames | 1 | 2015 | 212 | 0.030 |
Why?
|
| Transcription Initiation Site | 1 | 2014 | 33 | 0.030 |
Why?
|
| Evoked Potentials, Visual | 1 | 2014 | 35 | 0.030 |
Why?
|
| Genome, Mitochondrial | 1 | 2014 | 32 | 0.030 |
Why?
|
| Nucleotide Motifs | 1 | 2014 | 43 | 0.030 |
Why?
|
| RNA Editing | 1 | 2014 | 34 | 0.030 |
Why?
|
| X Chromosome | 3 | 2002 | 338 | 0.030 |
Why?
|
| Action Potentials | 1 | 1997 | 504 | 0.030 |
Why?
|
| Species Specificity | 1 | 2015 | 551 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2017 | 875 | 0.030 |
Why?
|
| Mechanoreceptors | 1 | 2013 | 11 | 0.030 |
Why?
|
| Afferent Pathways | 1 | 2013 | 21 | 0.030 |
Why?
|
| Lymph Nodes | 1 | 1996 | 378 | 0.030 |
Why?
|
| Hormones | 1 | 2014 | 186 | 0.030 |
Why?
|
| Candidiasis | 1 | 1995 | 129 | 0.030 |
Why?
|
| Proteins | 2 | 2014 | 1039 | 0.030 |
Why?
|
| Proprioception | 1 | 2013 | 20 | 0.030 |
Why?
|
| Human Genome Project | 2 | 2006 | 56 | 0.030 |
Why?
|
| Cats | 1 | 2013 | 119 | 0.030 |
Why?
|
| Touch | 1 | 2013 | 35 | 0.030 |
Why?
|
| Riboflavin | 1 | 2013 | 38 | 0.030 |
Why?
|
| Apolipoprotein A-V | 1 | 2013 | 19 | 0.030 |
Why?
|
| Algorithms | 2 | 2016 | 1633 | 0.030 |
Why?
|
| Skin | 1 | 2016 | 521 | 0.030 |
Why?
|
| Carnitine | 1 | 2013 | 74 | 0.030 |
Why?
|
| Ethics, Medical | 1 | 2016 | 396 | 0.030 |
Why?
|
| Adipose Tissue | 1 | 2016 | 465 | 0.030 |
Why?
|
| Vitamins | 1 | 2013 | 108 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2016 | 8272 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 1900 | 0.030 |
Why?
|
| Apolipoprotein A-I | 1 | 2013 | 81 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2014 | 405 | 0.030 |
Why?
|
| Leucine | 1 | 2014 | 310 | 0.030 |
Why?
|
| Proline | 1 | 2013 | 78 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2013 | 237 | 0.030 |
Why?
|
| Protein Kinases | 1 | 2014 | 331 | 0.030 |
Why?
|
| RNA Splicing | 1 | 2014 | 229 | 0.030 |
Why?
|
| Surgeons | 1 | 2017 | 257 | 0.030 |
Why?
|
| Health Care Costs | 1 | 2016 | 372 | 0.030 |
Why?
|
| DNA, Complementary | 2 | 2006 | 463 | 0.030 |
Why?
|
| Cost of Illness | 1 | 2014 | 253 | 0.030 |
Why?
|
| Audiometry, Pure-Tone | 1 | 2012 | 15 | 0.030 |
Why?
|
| Logistic Models | 1 | 2017 | 1808 | 0.030 |
Why?
|
| Auditory Threshold | 1 | 2012 | 17 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2012 | 25 | 0.030 |
Why?
|
| Recombination, Genetic | 2 | 2006 | 448 | 0.020 |
Why?
|
| Dogs | 1 | 2013 | 773 | 0.020 |
Why?
|
| Systems Biology | 1 | 2012 | 58 | 0.020 |
Why?
|
| Acoustic Stimulation | 1 | 2012 | 85 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2015 | 359 | 0.020 |
Why?
|
| Nerve Crush | 2 | 2001 | 8 | 0.020 |
Why?
|
| Arginine | 1 | 2014 | 335 | 0.020 |
Why?
|
| Leukemia | 1 | 1995 | 367 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 2017 | 675 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2018 | 12305 | 0.020 |
Why?
|
| Serine Endopeptidases | 1 | 2012 | 181 | 0.020 |
Why?
|
| Genetic Therapy | 1 | 2016 | 688 | 0.020 |
Why?
|
| Ligands | 1 | 2013 | 538 | 0.020 |
Why?
|
| Dementia | 1 | 2016 | 451 | 0.020 |
Why?
|
| Blotting, Southern | 1 | 1991 | 216 | 0.020 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2011 | 45 | 0.020 |
Why?
|
| Minisatellite Repeats | 1 | 2011 | 42 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2014 | 560 | 0.020 |
Why?
|
| Chromosome Banding | 1 | 2011 | 139 | 0.020 |
Why?
|
| Xenopus Proteins | 1 | 2011 | 61 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 586 | 0.020 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2011 | 74 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2013 | 586 | 0.020 |
Why?
|
| Prevalence | 1 | 2017 | 2469 | 0.020 |
Why?
|
| Liver | 1 | 2018 | 1749 | 0.020 |
Why?
|
| Triglycerides | 1 | 2013 | 576 | 0.020 |
Why?
|
| Amino Acids | 1 | 2013 | 668 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2012 | 670 | 0.020 |
Why?
|
| Menkes Kinky Hair Syndrome | 1 | 2010 | 3 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2012 | 1019 | 0.020 |
Why?
|
| Fibronectins | 2 | 2001 | 110 | 0.020 |
Why?
|
| Genetic Complementation Test | 1 | 2010 | 88 | 0.020 |
Why?
|
| Copper-transporting ATPases | 1 | 2010 | 23 | 0.020 |
Why?
|
| Genome, Fungal | 2 | 2000 | 32 | 0.020 |
Why?
|
| Copper | 1 | 2010 | 63 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2014 | 866 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2013 | 1361 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2012 | 634 | 0.020 |
Why?
|
| Locus Control Region | 1 | 2008 | 8 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2013 | 746 | 0.020 |
Why?
|
| Proto-Oncogenes | 1 | 2008 | 34 | 0.020 |
Why?
|
| DNA Primers | 1 | 2010 | 657 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2011 | 739 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2011 | 436 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2011 | 493 | 0.020 |
Why?
|
| Growth and Development | 1 | 2008 | 22 | 0.020 |
Why?
|
| DNA Restriction Enzymes | 1 | 1988 | 122 | 0.020 |
Why?
|
| Evoked Potentials | 1 | 2008 | 145 | 0.020 |
Why?
|
| Taste | 1 | 2008 | 32 | 0.020 |
Why?
|
| HLA-A24 Antigen | 1 | 2007 | 1 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2012 | 681 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2009 | 404 | 0.020 |
Why?
|
| Untranslated Regions | 1 | 2007 | 8 | 0.020 |
Why?
|
| Oogenesis | 1 | 2008 | 56 | 0.020 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2007 | 15 | 0.020 |
Why?
|
| Body Patterning | 1 | 2008 | 122 | 0.020 |
Why?
|
| Insecticides | 1 | 2008 | 52 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2012 | 1399 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2008 | 330 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1988 | 394 | 0.020 |
Why?
|
| Neurotransmitter Agents | 1 | 2008 | 147 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2017 | 3743 | 0.020 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2008 | 135 | 0.020 |
Why?
|
| Homozygote | 1 | 2009 | 548 | 0.020 |
Why?
|
| Vision, Ocular | 1 | 2008 | 122 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2012 | 1034 | 0.020 |
Why?
|
| Immunophenotyping | 1 | 2007 | 327 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2008 | 445 | 0.020 |
Why?
|
| Urinary Bladder | 1 | 2008 | 244 | 0.020 |
Why?
|
| Killer Cells, Natural | 1 | 2009 | 327 | 0.020 |
Why?
|
| Intercellular Junctions | 1 | 2006 | 25 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2007 | 398 | 0.020 |
Why?
|
| Proteome | 1 | 2008 | 246 | 0.020 |
Why?
|
| RNA Interference | 1 | 2008 | 508 | 0.020 |
Why?
|
| HLA-DRB3 Chains | 1 | 2005 | 2 | 0.020 |
Why?
|
| HLA-DQ alpha-Chains | 1 | 2005 | 17 | 0.020 |
Why?
|
| HLA-DRB1 Chains | 1 | 2005 | 38 | 0.020 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2007 | 143 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2009 | 1494 | 0.020 |
Why?
|
| DNA Repair | 1 | 2008 | 591 | 0.010 |
Why?
|
| Dosage Compensation, Genetic | 1 | 2005 | 59 | 0.010 |
Why?
|
| Crossing Over, Genetic | 1 | 2005 | 50 | 0.010 |
Why?
|
| Chromosomes, Human, Y | 1 | 2005 | 49 | 0.010 |
Why?
|
| Genetic Engineering | 1 | 2005 | 161 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2006 | 455 | 0.010 |
Why?
|
| Retroelements | 1 | 2004 | 41 | 0.010 |
Why?
|
| Chromosomes, Mammalian | 1 | 2004 | 41 | 0.010 |
Why?
|
| Genetics, Medical | 1 | 2005 | 119 | 0.010 |
Why?
|
| Aorta | 1 | 2007 | 545 | 0.010 |
Why?
|
| Graft vs Host Disease | 1 | 2007 | 503 | 0.010 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2004 | 161 | 0.010 |
Why?
|
| Switzerland | 1 | 2003 | 15 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 2006 | 357 | 0.010 |
Why?
|
| Models, Biological | 1 | 2008 | 1466 | 0.010 |
Why?
|
| Lod Score | 1 | 2003 | 120 | 0.010 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2005 | 298 | 0.010 |
Why?
|
| Testis | 1 | 2005 | 411 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2004 | 345 | 0.010 |
Why?
|
| DNA, Mitochondrial | 1 | 2004 | 211 | 0.010 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2003 | 156 | 0.010 |
Why?
|
| Prosencephalon | 1 | 2002 | 42 | 0.010 |
Why?
|
| Antigens, Neoplasm | 1 | 2005 | 384 | 0.010 |
Why?
|
| Receptor, Notch1 | 1 | 2002 | 66 | 0.010 |
Why?
|
| Fibroblast Growth Factor 5 | 1 | 2001 | 1 | 0.010 |
Why?
|
| Wallerian Degeneration | 1 | 2001 | 8 | 0.010 |
Why?
|
| Calcium-Binding Proteins | 1 | 2003 | 326 | 0.010 |
Why?
|
| Colforsin | 1 | 2001 | 51 | 0.010 |
Why?
|
| Integrin alpha4 | 1 | 2001 | 15 | 0.010 |
Why?
|
| Paxillin | 1 | 2001 | 13 | 0.010 |
Why?
|
| PC12 Cells | 1 | 2001 | 25 | 0.010 |
Why?
|
| Growth Cones | 1 | 2001 | 16 | 0.010 |
Why?
|
| Rats, Inbred Lew | 1 | 2001 | 68 | 0.010 |
Why?
|
| Heart | 1 | 2006 | 731 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2002 | 257 | 0.010 |
Why?
|
| Marfan Syndrome | 1 | 2003 | 143 | 0.010 |
Why?
|
| Ganglia, Spinal | 1 | 2001 | 71 | 0.010 |
Why?
|
| Peripheral Nerve Injuries | 1 | 2001 | 37 | 0.010 |
Why?
|
| Urine | 1 | 2001 | 91 | 0.010 |
Why?
|
| Plasmids | 1 | 1982 | 513 | 0.010 |
Why?
|
| Sequence Tagged Sites | 1 | 2001 | 27 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 2001 | 85 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2001 | 461 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 2001 | 247 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2001 | 347 | 0.010 |
Why?
|
| RNA-Induced Silencing Complex | 1 | 2000 | 12 | 0.010 |
Why?
|
| Argonaute Proteins | 1 | 2000 | 26 | 0.010 |
Why?
|
| Genomic Library | 1 | 2000 | 42 | 0.010 |
Why?
|
| beta Catenin | 1 | 2001 | 214 | 0.010 |
Why?
|
| Chromosomes, Bacterial | 1 | 2000 | 64 | 0.010 |
Why?
|
| Helminth Proteins | 1 | 2000 | 101 | 0.010 |
Why?
|
| ATP Binding Cassette Transporter 1 | 1 | 1999 | 19 | 0.010 |
Why?
|
| Polysaccharide-Lyases | 1 | 1999 | 2 | 0.010 |
Why?
|
| Pepsin A | 1 | 1999 | 12 | 0.010 |
Why?
|
| Spermatogenesis | 1 | 2000 | 172 | 0.010 |
Why?
|
| Chromosome Deletion | 1 | 1982 | 652 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2005 | 2184 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 1999 | 109 | 0.010 |
Why?
|
| Proteoglycans | 1 | 1999 | 88 | 0.010 |
Why?
|
| Ascorbic Acid | 1 | 1999 | 78 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1999 | 387 | 0.010 |
Why?
|
| Research Design | 1 | 2002 | 694 | 0.010 |
Why?
|
| Risk Factors | 1 | 2013 | 10301 | 0.010 |
Why?
|
| Receptors, Notch | 1 | 2000 | 205 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2001 | 772 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 1998 | 140 | 0.010 |
Why?
|
| Comorbidity | 1 | 2003 | 1532 | 0.010 |
Why?
|
| Extracellular Matrix | 1 | 1999 | 238 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2001 | 1400 | 0.010 |
Why?
|
| Echocardiography | 1 | 2003 | 1066 | 0.010 |
Why?
|
| Gene Library | 1 | 1998 | 218 | 0.010 |
Why?
|
| Heparin | 1 | 1999 | 216 | 0.010 |
Why?
|
| Cell Division | 1 | 1999 | 780 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2001 | 781 | 0.010 |
Why?
|
| Drosophila Proteins | 1 | 2000 | 713 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2001 | 4595 | 0.000 |
Why?
|